NCT07743541
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07743541
Title Study of TUB-040 in Patients With Recurrent or Progressive Uterine Cancer After Chemotherapy and Immune Therapy (NAPISTAR 1-03)
Acronym NAPISTAR 1-03
Recruitment Not yet recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Tubulis GmbH
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
START Los Angeles Los Angeles California 90025 United States Details
START New Jersey East Brunswick New Jersey 08816 United States Details
START New York-Long Island Lake Success New York 11042 United States Details
START Mountain Region, LLC West Valley City Utah 84119 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field